A significant number of genetic variants that are associated with type-2 DM and metabolic disorders are localized 3–48 kb upstream of KLF14, and an association of several SNPs affecting the KLF14 expression levels have been identified in adipose tissues [48,49], making it a master regulator implicated in metabolic syndrome [46]. The gene discussed is KLF14; the disease is metabolic syndrome.